4//SEC Filing
Drutz David 4
Accession 0001104659-22-104780
CIK 0001326190other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 9:22 PM ET
Size
5.6 KB
Accession
0001104659-22-104780
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Award
Stock Options (option to buy)
2022-09-29+23,500→ 23,500 totalExercise: $12.62Exp: 2032-09-29→ Common Stock, par value $0.0001 (23,500 underlying)
Footnotes (1)
- [F1]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001428764
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 9:22 PM ET
- Size
- 5.6 KB